F-group (family)
212.1.1.7 IGPD
Ligands and drugs
1,649
Member domains
519
with ligand contacts (≤ 4 Å)
31.5% of members
272
with DrugDomain annotations
16.5% of members
64
with a DrugBank compound
3.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 212.1.1.7 belongs to X-group 212 Ribosomal protein S5 domain 2-like, which binds 9.4 ligand superclasses per 20 proteins, broader than 86% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02736 | ACM | Acetamide | 2 |
| DB03594 | TRI | 1,2,4-Triazole | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MNmetal | MANGANESE (II) ION | 497 |
| 5LD | [(2R)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]phosphonic acid | 128 |
| 3TR | 3-AMINO-1,2,4-TRIAZOLE | 49 |
| IG2 | (2S,3S)-2,3-dihydroxy-3-(1H-imidazol-5-yl)propyl dihydrogen phosphate | 49 |
| CL | CHLORIDE ION | 14 |
| MGmetal | MAGNESIUM ION | 13 |
| NAmetal | SODIUM ION | 11 |
| IYP | (2R,3S)-2,3-dihydroxy-3-(1H-imidazol-5-yl)propyl dihydrogen phosphate | 6 |
| 5DL | [(2S)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl]phosphonic acid | 4 |
| EMC | ETHYL MERCURY ION | 4 |
| 47Z | (1S)-2-methyl-1-(2-methyl-1,2,4-triazol-3-yl)propan-1-amine | 2 |
| H3L | (1S)-1-(2-methyl-1,2,4-triazol-3-yl)ethanamine | 2 |
| HGmetal | MERCURY (II) ION | 2 |
| 83O | (2S)-2-azanyl-3-(4H-1,2,4-triazol-3-yl)propanoic acid | 1 |
| HB3 | 2-(1H-1,2,4-triazol-5-ylsulfanyl)ethanamine | 1 |
| TRI | 1,2,4-TRIAZOLE | 1 |